This paper is only available as a PDF. To read, Please Download here.
This paper describes the results from a randomized clinical trial comparing the Collatex vaginal contraceptive sponge (a predecessor of the Today™ sponge) and Neo Sampoon foaming vaginal contraceptive tablets; the trial was conducted from 1979 to 1983 in four centers located in three countries (two in Yugoslavia and one each in Taiwan and Bangladesh).
The sponge was associated with more insertion and retention problems than the tablet, especially in the two Asian centers. More Neo Sampoon users complained of a burning or stinging sensation. This complaint, however, seemed to be well-tolerated and was not a frequent reason for irregular use and/or discontinuation of use of the tablets. Clinically significant medical complications were rarely reported for either method. Sponge users were more likely to report irregular use than tablet users, primarily due to inconvenience of use. Rates of discontinuation at six months of use were also consistently higher among sponge users than Neo Sampoon users in the four centers. Life-table pregnancy rates at 12 months of use ranged from 3.8 to 18.2 per 100 sponge users and 6.2 to 29.9 per 100 Neo Sampoon users, based on data from the two Yugoslavian centers and the Taiwan center (data from the Bangladesh center were excluded from analysis of pregnancy rates). Practical implications of these findings are discussed.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Contraception
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- The IUD still has an important place in family planning.IPPF Medical Bulletin. 1986; 20: 2
- Effect of the contraceptive sponge on chlamydial infection gonorrhea and candidiasis.JAMA. 1987; 257: 2308
- Vaginal Contraceptives: A time for reappraisal?.Popul. Rep., [H] No. 3. 1975;
- Spermicides—simplicity and safety are major assets.Popul. Rep., [H] No. 5. 1979;
- Use-effectiveness of intrauterine contraception as a problem in competing risks.in: Freedman R Takeshita J Family Planning in Taiwan. Princeton University Press, Princeton1969: 458
- A new procedure for the statistical evaluation of intrauterine contraception.Am J Obstet Gynecol. 1977; 128: 329
- Statistical aspects of analysis of data from retrospective studies of diseases.J. Natl. Cancer Inst. 1959; 22: 719
- Spermicidal agents: effectiveness use and testing.in: Zatuchni G.I. Vaginal Contraception: New Developments. Harper & Row, Hagerstown1979: 48
- Clinical field test of a new contraceptive vaginal foam tablet.Contraception. 1972; 6: 401
- A comparative trial of the Today™ contraceptive sponge and diaphragm.Am J Obstet Gynecol. 1984; 150: 869
- Parity and use-effectiveness with the contraceptive sponge.Am J Obstet Gynecol. 1986; 155: 796
- New developments in vaginal contraception.Population Reports, [H] No. 7. 1984;
- The cultural acceptability of vaginal contraceptives.in: Zatuchni G.I. Vaginal Contraception: New Developments. Harper & Row, Hagerstown1979: 282
Accepted: October 28, 1987
Received: September 21, 1987
© 1987 Published by Elsevier Inc.